Cibc World Markets Corp Invests $311,000 in ICU Medical, Inc. (NASDAQ:ICUI)

Cibc World Markets Corp acquired a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 2,006 shares of the medical instruments supplier's stock, valued at approximately $311,000.

Other hedge funds have also added to or reduced their stakes in the company. State Street Corp raised its position in shares of ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock worth $165,384,000 after purchasing an additional 77,506 shares during the period. Geode Capital Management LLC raised its holdings in ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock worth $99,687,000 after buying an additional 48,106 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of ICU Medical by 1.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 304,155 shares of the medical instruments supplier's stock worth $47,196,000 after acquiring an additional 3,048 shares during the period. Principal Financial Group Inc. raised its holdings in shares of ICU Medical by 4.1% during the fourth quarter. Principal Financial Group Inc. now owns 132,099 shares of the medical instruments supplier's stock worth $20,498,000 after acquiring an additional 5,162 shares during the period. Finally, FMR LLC boosted its stake in ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock worth $18,968,000 after purchasing an additional 100,345 shares during the period. Institutional investors and hedge funds own 96.10% of the company's stock.

Remove Ads

ICU Medical Stock Down 2.9 %

ICUI traded down $4.12 during trading on Friday, reaching $140.16. 224,230 shares of the stock were exchanged, compared to its average volume of 262,407. The stock has a market cap of $3.44 billion, a P/E ratio of -30.67 and a beta of 0.73. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The stock's 50 day moving average price is $154.89 and its two-hundred day moving average price is $164.01. ICU Medical, Inc. has a twelve month low of $93.36 and a twelve month high of $196.26.

Insider Buying and Selling at ICU Medical

In other news, CEO Vivek Jain sold 1,373 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 6.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target on the stock in a report on Wednesday, December 11th. Raymond James set a $97.00 price target on shares of ICU Medical in a research note on Wednesday, March 12th. Finally, StockNews.com lowered shares of ICU Medical from a "buy" rating to a "hold" rating in a research report on Thursday. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $168.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.